Using viral barcode tracing to detect interactions between glioblastoma cells and non-malignant astrocytes in patient samples, investigators discovered a pathway that reduces tumour-specific immunity and identified potential therapeutic targets.
- Brian M. Andersen
- Camilo Faust Akl
- Francisco J. Quintana